Alnylam Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 80,252 | 0.1% | 201,816 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 92,923 | 0.1% | 203,778 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 64,995 | 0.1% | 199,316 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 53,314 | 0.1% | 197,443 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 46,206 | 0.1% | 196,362 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 52,620 | 0.1% | 191,325 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 47,043 | 0.1% | 193,594 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 28,607 | 0.0% | 191,418 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 36,670 | 0.1% | 191,578 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 33,690 | 0.1% | 190,231 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 37,722 | 0.1% | 198,598 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 40,717 | 0.1% | 203,262 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 47,941 | 0.1% | 201,731 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 39,702 | 0.1% | 198,351 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 29,166 | 0.0% | 199,971 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 32,529 | 0.0% | 199,213 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 35,566 | 0.0% | 209,732 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 38,780 | 0.0% | 205,392 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 35,571 | 0.0% | 209,831 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 30,536 | 0.0% | 216,276 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 27,977 | 0.0% | 215,256 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 30,672 | 0.0% | 210,657 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 30,195 | 0.1% | 203,868 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 20,378 | 0.0% | 187,208 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 21,485 | 0.0% | 186,553 | 12/31/2019 |
| 2014 Q1 | 5/8/2014 | 7,100 | 0.0% | 105,754 | 3/31/2014 |
| 2013 Q4 | 2/10/2014 | 6,771 | 0.0% | 105,254 | 12/31/2013 |